Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference
February 26 2014 - 08:00AM
PR Newswire (US)
SEATTLE, WA,
Feb. 26, 2014 /PRNewswire/ -
Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief
Executive Officer, will present at the Cowen and Company
34th Annual Health Care Conference in Boston on Wednesday,
March 5, 2014 at 9:20 a.m.
Eastern.
A live and archived webcast of the presentation will be
accessible by visiting the Oncothyreon website www.oncothyreon.com
under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the
development of innovative therapeutic products for the treatment of
cancer. Oncothyreon's goal is to develop and commercialize novel
synthetic vaccines and targeted small molecules that have the
potential to improve the lives and outcomes of cancer patients. For
more information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
Copyright 2014 PR Newswire
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Cascadian Therapeutics, Inc. (NASDAQ:CASC)
Historical Stock Chart
From Mar 2023 to Mar 2024